Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, et al. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients. Sci Transl Med. 2015 Apr 15;7(283):283ra55. PubMed PMID: 25877893.
Commo F, Ferté C, Soria JC, Friend SH, André F, et al. Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology. Ann Oncol. 2015 Mar;26(3):582-8. PubMed PMID: 25538175; PubMed Central PMCID: PMC4343013.
Albiges L, Goubar A, Scott V, Vicier C, Lefèbvre C, et al. Chk1 as a new therapeutic target in triple-negative breast cancer. Breast. 2014 Jun;23(3):250-8. PubMed PMID: 24636978.
André F, Bachelot T, Commo F, Campone M, Arnedos M, et al. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol. 2014 Mar;15(3):267-74. PubMed PMID: 24508104.
Cortot AB, Younes M, Martel-Planche G, Guibert B, Isaac S, et al. Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas. Clin Lung Cancer. 2014 Mar;15(2):124-30. PubMed PMID: 24169260.
Nakouzi NA, Cotteret S, Commo F, Gaudin C, Rajpar S, et al. Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer. Oncotarget. 2014 Feb 15;5(3):667-78. PubMed PMID: 24525428; PubMed Central PMCID: PMC3996665.
Broutin S, Commo F, De Koning L, Marty-Prouvost B, Lacroix L, et al. Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein array. Thyroid. 2014 Jan;24(1):43-51. PubMed PMID: 24256343.
Friboulet L, Postel-Vinay S, Sourisseau T, Adam J, Stoclin A, et al. ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform. Cell Cycle. 2013 Oct 15;12(20):3298-306. PubMed PMID: 24036546; PubMed Central PMCID: PMC3885640.
Alsafadi S, Even C, Falet C, Goubar A, Commo F, et al. Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8. PubMed PMID: 23830798.
Vanhecke E, Valent A, Tang X, Vielh P, Friboulet L, et al. 19q13-ERCC1 gene copy number increase in non--small-cell lung cancer. Clin Lung Cancer. 2013 Sep;14(5):549-57. PubMed PMID: 23773262.
Ferté C, Trister AD, Huang E, Bot BM, Guinney J, et al. Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology. Clin Cancer Res. 2013 Aug 15;19(16):4315-25. PubMed PMID: 23780890; NIHMSID: NIHMS492787; PubMed Central PMCID: PMC3745509.
Broutin S, Commo F, De Koning L, Marty-Prouvost B, Lacroix L, et al. Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein array. Thyroid. 2013 Jul 3;PubMed PMID: 23822199.
Ferté C, Loriot Y, Clémenson C, Commo F, Gombos A, et al. IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy. Mol Cancer Ther. 2013 Jul;12(7):1213-22. PubMed PMID: 23640142; NIHMSID: NIHMS476619; PubMed Central PMCID: PMC3707930.
Rusakiewicz S, Semeraro M, Sarabi M, Desbois M, Locher C, et al. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors. Cancer Res. 2013 Jun 15;73(12):3499-510. PubMed PMID: 23592754.
Vignot S, Frampton GM, Soria JC, Yelensky R, Commo F, et al. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. J Clin Oncol. 2013 Jun 10;31(17):2167-72. PubMed PMID: 23630207.
Olaussen KA, Adam J, Vanhecke E, Vielh P, Pirker R, et al. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs. Lung Cancer. 2013 May;80(2):216-22. PubMed PMID: 23410825.
Quidville V, Alsafadi S, Goubar A, Commo F, Scott V, et al. Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy. Cancer Res. 2013 Apr 1;73(7):2247-58. PubMed PMID: 23358685.
Friboulet L, Olaussen KA, Pignon JP, Shepherd FA, Tsao MS, et al. ERCC1 isoform expression and DNA repair in non-small-cell lung cancer. N Engl J Med. 2013 Mar 21;368(12):1101-10. PubMed PMID: 23514287; NIHMSID: NIHMS583600; PubMed Central PMCID: PMC4054818.
Prada N, Antoni G, Commo F, Rusakiewicz S, Semeraro M, et al. Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort. Oncoimmunology. 2013 Mar 1;2(3):e23472. PubMed PMID: 23802087; PubMed Central PMCID: PMC3661172.
Arnedos M, Scott V, Job B, De La Cruz J, Commo F, et al. Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer. Eur J Cancer. 2012 Oct;48(15):2293-9. PubMed PMID: 22840369.
Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep. 2012 Aug 30;2(2):257-69. PubMed PMID: 22854025.
Gauler TC, Besse B, Mauguen A, Meric JB, Gounant V, et al. Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC). Ann Oncol. 2012 Mar;23(3):678-87. PubMed PMID: 21617019.
Friboulet L, Barrios-Gonzales D, Commo F, Olaussen KA, Vagner S, et al. Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC. Clin Cancer Res. 2011 Sep 1;17(17):5562-72. PubMed PMID: 21750204.
Delahaye NF, Rusakiewicz S, Martins I, Ménard C, Roux S, et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med. 2011 Jun;17(6):700-7. PubMed PMID: 21552268.
Peyre M, Commo F, Dantas-Barbosa C, Andreiuolo F, Puget S, et al. Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis. PLoS One. 2010 Sep 24;5(9):e12932. PubMed PMID: 20885975; PubMed Central PMCID: PMC2945762.
Raynaud CM, Hernandez J, Llorca FP, Nuciforo P, Mathieu MC, et al. DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. Am J Clin Oncol. 2010 Aug;33(4):341-5. PubMed PMID: 19884805.
Raynaud CM, Mercier O, Dartevelle P, Commo F, Olaussen KA, et al. Expression of chemokine receptor CCR6 as a molecular determinant of adrenal metastatic relapse in patients with primary lung cancer. Clin Lung Cancer. 2010 May;11(3):187-91. PubMed PMID: 20439195.
Olaussen KA, Commo F, Tailler M, Lacroix L, Vitale I, et al. Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines. Oncogene. 2009 Dec 3;28(48):4249-60. PubMed PMID: 19749798.
Planchard D, Loriot Y, Goubar A, Commo F, Soria JC. Differential expression of biomarkers in men and women. Semin Oncol. 2009 Dec;36(6):553-65. PubMed PMID: 19995647.
Gomez-Roca C, Raynaud CM, Penault-Llorca F, Mercier O, Commo F, et al. Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites. J Thorac Oncol. 2009 Oct;4(10):1212-20. PubMed PMID: 19687761.
Raynaud CM, Mercier O, Commo F, Dartevelle P, Gomez-Roca C, et al. Telomere length, telomeric proteins and DNA damage repair proteins are differentially expressed between primary lung tumors and their adrenal metastases. Lung Cancer. 2009 Aug;65(2):144-9. PubMed PMID: 19091442.
Brun JL, Cortez A, Commo F, Uzan S, Rouzier R, et al. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2. Int J Oncol. 2008 Dec;33(6):1239-46. PubMed PMID: 19020757.
Lacroix L, Commo F, Soria JC. Gene expression profiling of non-small-cell lung cancer. Expert Rev Mol Diagn. 2008 Mar;8(2):167-78. PubMed PMID: 18366303.
Allory Y, Commo F, Boccon-Gibod L, Sibony M, Callard P, et al. Sulfated HNK-1 epitope in developing and mature kidney: a new marker for thin ascending loop of Henle and tubular injury in acute tubular necrosis. J Histochem Cytochem. 2006 May;54(5):575-84. PubMed PMID: 16401697.
Assémat E, Châtelet F, Chandellier J, Commo F, Cases O, et al. Overlapping expression patterns of the multiligand endocytic receptors cubilin and megalin in the CNS, sensory organs and developing epithelia of the rodent embryo. Gene Expr Patterns. 2005 Dec;6(1):69-78. PubMed PMID: 16027047.
Dagnon K, Pacary E, Commo F, Antoine M, Bernaudin M, et al. Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. Clin Cancer Res. 2005 Feb 1;11(3):993-9. PubMed PMID: 15709164.
Truong K, Gibaud A, Zalcman G, Guilly MN, Antoine M, et al. Quantitative fish determination of chromosome 3 arm imbalances in lung tumors by automated image cytometry. Med Sci Monit. 2004 Nov;10(11):BR426-32. PubMed PMID: 15507848.
Barranger E, Cortez A, Commo F, Marpeau O, Uzan S, et al. Histopathological validation of the sentinel node concept in cervical cancer. Ann Oncol. 2004 Jun;15(6):870-4. PubMed PMID: 15151942.
Fouquet C, Antoine M, Tisserand P, Favis R, Wislez M, et al. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study. Clin Cancer Res. 2004 May 15;10(10):3479-89. PubMed PMID: 15161705.
Hertig A, Berrou J, Allory Y, Breton L, Commo F, et al. Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta. FASEB J. 2003 Oct;17(13):1904-6. PubMed PMID: 12897066.
Ibrahim EC, Allory Y, Commo F, Gattegno B, Callard P, et al. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. Am J Pathol. 2003 Feb;162(2):501-8. PubMed PMID: 12547708; PubMed Central PMCID: PMC1851152.
Soria JC, Morat L, Commo F, Dabit D, Perie S, et al. Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis. Br J Cancer. 2001 Feb;84(4):504-11. PubMed PMID: 11207046; PubMed Central PMCID: PMC2363771.
Wioland MA, Fleury-Feith J, Corlieu P, Commo F, Monceaux G, et al. CFTR, MDR1, and MRP1 immunolocalization in normal human nasal respiratory mucosa. J Histochem Cytochem. 2000 Sep;48(9):1215-22. PubMed PMID: 10950878.
Lechapt-Zalcman E, Hurbain I, Lacave R, Commo F, Urban T, et al. MDR1-Pgp 170 expression in human bronchus. Eur Respir J. 1997 Aug;10(8):1837-43. PubMed PMID: 9272928.
Commo F, Sibony M, Antoine M, Fouret P, Callard P. [Effect of microwave pretreatment on the detection of Epstein-Barr virus EBER RNA's using in situ hybridization]. Ann Pathol. 1996;16(1):61-4. PubMed PMID: 8652007.
Sibony M, Commo F, Callard P, Gasc JM. Enhancement of mRNA in situ hybridization signal by microwave heating. Lab Invest. 1995 Oct;73(4):586-91. PubMed PMID: 7474931.
Fouret P, Dabit D, Sibony M, Alili D, Commo F, et al. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx. Am J Pathol. 1995 Mar;146(3):599-604. PubMed PMID: 7887442; PubMed Central PMCID: PMC1869193.
